Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 6.00
+0.05 (0.78%)
May 9, 2025, 12:30 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 6.74 million as of May 9, 2025. Its market cap has increased by 88.54% in one year.
Market Cap
6.74M
Enterprise Value
6.34M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.00
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 6.74M, a decrease of -75.29%. That is a compound annual growth rate of -17.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 162.88B |
| GSK plc | 56.05B |
| Haleon | 36.35B |
| Smith & Nephew | 9.26B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.37B |